Canadian Imperial Bank of Commerce Publication of Suppl.Prospcts (4527Z)

TIDMBH29

RNS Number : 4527Z

Canadian Imperial Bank of Commerce

31 August 2018

Regulatory Announcement

Canadian Imperial Bank of Commerce

31 August 2018

Publication of Supplementary Prospectus

The following supplementary prospectus has been approved by the UK Listing Authority and is available for viewing:

First supplementary prospectus dated 31 August 2018 (the "Supplementary Prospectus") relating to the the base prospectus dated 14 June 2018, as supplemented by the first combined supplementary prospectus dated 24 August 2018, in relation to CIBC's USD 20,000,000,000 Note Issuance Programme (the "Prospectus"), as issued by Canadian Imperial Bank of Commerce ("CIBC").

The Supplementary Prospectus, together with the document incorporated by reference therein, have been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/nsm.

To view the Supplementary Prospectus and the document incorporated by reference therein, please click on the links below or alternatively paste the following URL's into the address bar of your Internet browser.

Supplementary Prospectus dated 31 August 2018:

http://www.rns-pdf.londonstockexchange.com/rns/4527Z_1-2018-8-31.pdf

Document partially or entirely incorporated by reference:

The section entitled "Terms and Conditions of the Notes" set out in CIBC's base prospectus dated 7 June 2017;

https://www.rns-pdf.londonstockexchange.com/rns/5747H_-2017-6-8.pdf?_ga=2.99098270.1058079080.1535569842-637319952.1528908006

For further information, please contact:

Michelle Caturay

Senior Vice-President, Associate General Counsel,

Corporate Secretary and Chief Privacy Officer

Canadian Imperial Bank of Commerce

Telephone Number: [phone]

Fax Number: [phone]

Email: [e-mail]

DISCLAIMER -- INTENDED ADDRESSEES

Please note that the information contained in the Prospectus, as supplemented by the Supplementary Prospectus dated 31 August 2018 (collectively, the "Disclosure Documents") is addressed to and/or targeted at persons who are residents of particular countries only (as specified in the Disclosure Documents) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in either Base Prospectus is not addressed. Prior to relying on the information contained in the Disclosure Documents you must ascertain from the Disclosure Documents whether or not you are an intended addressee of the information contained therein.

The Programme Notes (as defined in the Prospectus) have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold within the United States or to or for the account or benefit of U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

Your right to access this service is conditional upon complying with the above requirements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

PSPBXGDIIBXBGIB

(END) Dow Jones Newswires

August 31, 2018 09:21 ET (13:21 GMT)